These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2534316)
1. Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG). Tsuchiya Y; Igarashi M; Inoue M; Kumagai K J Pharmacobiodyn; 1989 Oct; 12(10):616-25. PubMed ID: 2534316 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of anti-tumor effect of interleukin 2 with sizofiran in mice. Ikeuchi K Keio J Med; 1991 Sep; 40(3):132-8. PubMed ID: 1753556 [TBL] [Abstract][Full Text] [Related]
3. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages. Sugawara I; Lee KC; Wong M Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of natural killer (NK) cell recovery by a glucan, sizofiran, in anti-asialoGM1 antibody-treated mice. Tsuchiya Y; Yang ZB; Nakahashi S; Arika T Int J Immunopharmacol; 1993 Oct; 15(7):783-92. PubMed ID: 8262692 [TBL] [Abstract][Full Text] [Related]
5. [Effect of schizophyllan on delayed hypersensitivity in the mouse (author's transl)]. Suzuki M; Komatsu N Jpn J Antibiot; 1977 Jun; 30(6):356-61. PubMed ID: 142850 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of the antitumor effect of adoptive immunotherapy by in vivo sensitization of EL-4 lymphoma and pre-treatment with sizofiran. Kano Y; Kakuta H; Hashimoto J Biotherapy; 1998; 11(1):1-6. PubMed ID: 9617459 [TBL] [Abstract][Full Text] [Related]
7. Failure in antitumor activity by overdose of an immunomodulating beta-glucan preparation, sonifilan. Miura T; Miura NN; Ohno N; Adachi Y; Shimada S; Yadomae T Biol Pharm Bull; 2000 Feb; 23(2):249-53. PubMed ID: 10706395 [TBL] [Abstract][Full Text] [Related]
8. Schizophyllum commune β-glucan: Effect on interleukin-10 expression induced by lipopolysaccharide from periodontopathic bacteria. Thongsiri C; Nagai-Yoshioka Y; Yamasaki R; Adachi Y; Usui M; Nakashima K; Nishihara T; Ariyoshi W Carbohydr Polym; 2021 Feb; 253():117285. PubMed ID: 33278951 [TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory effects of sizofiran (SPG) on lymphocytes and polymorphonuclear leukocytes. Yoneda K; Ueta E; Yamamoto T; Osaki T Clin Exp Immunol; 1991 Nov; 86(2):229-35. PubMed ID: 1657462 [TBL] [Abstract][Full Text] [Related]
10. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice. Tsuzuki A; Tateishi T; Ohno N; Adachi Y; Yadomae T Biosci Biotechnol Biochem; 1999 Jan; 63(1):104-10. PubMed ID: 10052129 [TBL] [Abstract][Full Text] [Related]
11. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1-->3)-beta-D-glucan preparation, sonifilan. Hirata N; Tsuzuki A; Ohno N; Saita M; Adachi Y; Yadomae T Zentralbl Bakteriol; 1998 Nov; 288(3):403-13. PubMed ID: 9861684 [TBL] [Abstract][Full Text] [Related]
12. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
13. Effect of sizofiran on regional lymph nodes in patients with head and neck cancer. Kano Y; Kakuta H; Hashimoto J Biotherapy; 1996; 9(4):257-62. PubMed ID: 9012545 [TBL] [Abstract][Full Text] [Related]
14. The roles of interleukins in the synergistic effect of B-cell mitogens with concanavalin A on hydrocortisone-resistant thymic cell proliferation. Nitta T; Konno-Ejiri H; Nemoto K; Okumura S; Ozawa A; Nakano M Immunology; 1986 Oct; 59(2):209-16. PubMed ID: 3490433 [TBL] [Abstract][Full Text] [Related]
15. Effects of an anti-tumor polysaccharide, schizophyllan, on interferon-gamma and interleukin 2 production by peripheral blood mononuclear cells. Sakagami Y; Mizoguchi Y; Shin T; Seki S; Kobayashi K; Morisawa S; Yamamoto S Biochem Biophys Res Commun; 1988 Sep; 155(2):650-5. PubMed ID: 2971353 [TBL] [Abstract][Full Text] [Related]
16. In vitro activation of human adherent cells by a glucan, Schizophyllan. Mashiba H; Matsunaga K Jpn J Exp Med; 1983 Aug; 53(4):195-8. PubMed ID: 6229661 [TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory and antitumor activity of schizophyllan under ultrasonic treatment. Zhong K; Tong L; Liu L; Zhou X; Liu X; Zhang Q; Zhou S Int J Biol Macromol; 2015 Sep; 80():302-8. PubMed ID: 26126943 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of antitumor effect by combined administration with interleukin-2 and sizofiran, a single glucan, on murine EL-4 lymphoma. Kano Y; Kakuta H; Hashimoto J Biotherapy; 1996; 9(4):241-7. PubMed ID: 9012543 [TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy of malignant lymphoma with interleukin-2 and sizofiran--a basic study on EL-4 lymphoma-transplanted mice]. Hashimoto J Nihon Jibiinkoka Gakkai Kaiho; 1994 Jul; 97(7):1235-49. PubMed ID: 8064508 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras. Billiau AD; Sefrioui H; Overbergh L; Rutgeerts O; Goebels J; Mathieu C; Waer M Transplantation; 2001 Jan; 71(2):292-9. PubMed ID: 11213076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]